TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Predict S.P.A. Class B ( (IT:PRE) ) has provided an update.
Predict S.p.A., as part of a Temporary Grouping of Companies led by Exprivia S.p.A., has secured a framework agreement with InnovaPuglia S.p.A. for ICT services in the healthcare sector, valued at approximately 14.4 million euros over 48 months. This agreement aligns with the PugliaDigitale2030 Agenda, aiming to enhance regional digital growth and support local administrations with advanced technological solutions, including augmented reality and AI, to improve healthcare services.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative SME in the healthcare sector, specializing in in vivo diagnostics through ultrasound and radiological equipment, and developing technologies in breath analysis and digital healthcare. The company is organized into four Strategic Business Units, focusing on diagnostic imaging, breath analysis, and digital healthcare solutions, including augmented reality and robotics. Predict has established partnerships with major Italian research institutes and universities.
Average Trading Volume: 32,133
Technical Sentiment Signal: Strong Buy
Find detailed analytics on PRE stock on TipRanks’ Stock Analysis page.